The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Highlights
The global Sleeplessness and Circadian Rhythm Disorder Treatment market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Sleeplessness and Circadian Rhythm Disorder Treatment is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Sleeplessness and Circadian Rhythm Disorder Treatment is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The global market for Sleeplessness and Circadian Rhythm Disorder Treatment in Hospital is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global companies of Sleeplessness and Circadian Rhythm Disorder Treatment include Lanaform, Compass Health Brands (Carex Health), Compumedics, Natus Medical, Teva Pharmaceuticals, Lucimed (Luminette), Garmin, Koninklijke Philips and Mylan, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, Drug Therapy, which accounted for % of the global market of Sleeplessness and Circadian Rhythm Disorder Treatment in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sleeplessness and Circadian Rhythm Disorder Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sleeplessness and Circadian Rhythm Disorder Treatment.
The Sleeplessness and Circadian Rhythm Disorder Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Sleeplessness and Circadian Rhythm Disorder Treatment market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sleeplessness and Circadian Rhythm Disorder Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Some of the prominent players reviewed in the research report include:
- Lanaform
- Compass Health Brands (Carex Health)
- Compumedics
- Natus Medical
- Teva Pharmaceuticals
- Lucimed (Luminette)
- Garmin
- Koninklijke Philips
- Mylan
- Fitbit
- Takeda Pharmaceutical
- F.Hoffman La-Roche Ag
- Merck & Co. Inc.
- Pfizer, Inc.
- Pernix Therapeutics
- Sanofi S.A.
- Sumitomo Dainippon Pharma Co., Ltd
- Vanda Pharmaceuticals, Inc.
Product Type Insights
Global markets are presented by Sleeplessness and Circadian Rhythm Disorder Treatment type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Sleeplessness and Circadian Rhythm Disorder Treatment are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Sleeplessness and Circadian Rhythm Disorder Treatment segment by Type
- Drug Therapy
- Light Therapy
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Sleeplessness and Circadian Rhythm Disorder Treatment market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Sleeplessness and Circadian Rhythm Disorder Treatment market.
Sleeplessness and Circadian Rhythm Disorder Treatment Segment by Application
- Hospital
- Specialist Clinic
- Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina, Colombia)
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Sleeplessness and Circadian Rhythm Disorder Treatment market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sleeplessness and Circadian Rhythm Disorder Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Sleeplessness and Circadian Rhythm Disorder Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
- This report stays updated with novel technology integration, features, and the latest developments in the market
- This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Sleeplessness and Circadian Rhythm Disorder Treatment industry.
- This report helps stakeholders to gain insights into which regions to target globally
- This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sleeplessness and Circadian Rhythm Disorder Treatment.
- This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sleeplessness and Circadian Rhythm Disorder Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Drug Therapy
1.2.3 Light Therapy
1.3 Market by Application
1.3.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Specialist Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Perspective (2017-2028)
2.2 Sleeplessness and Circadian Rhythm Disorder Treatment Growth Trends by Region
2.2.1 Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Sleeplessness and Circadian Rhythm Disorder Treatment Historic Market Size by Region (2017-2022)
2.2.3 Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Region (2023-2028)
2.3 Sleeplessness and Circadian Rhythm Disorder Treatment Market Dynamics
2.3.1 Sleeplessness and Circadian Rhythm Disorder Treatment Industry Trends
2.3.2 Sleeplessness and Circadian Rhythm Disorder Treatment Market Drivers
2.3.3 Sleeplessness and Circadian Rhythm Disorder Treatment Market Challenges
2.3.4 Sleeplessness and Circadian Rhythm Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sleeplessness and Circadian Rhythm Disorder Treatment Players by Revenue
3.1.1 Global Top Sleeplessness and Circadian Rhythm Disorder Treatment Players by Revenue (2017-2022)
3.1.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sleeplessness and Circadian Rhythm Disorder Treatment Revenue
3.4 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Concentration Ratio
3.4.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in 2021
3.5 Sleeplessness and Circadian Rhythm Disorder Treatment Key Players Head office and Area Served
3.6 Key Players Sleeplessness and Circadian Rhythm Disorder Treatment Product Solution and Service
3.7 Date of Enter into Sleeplessness and Circadian Rhythm Disorder Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sleeplessness and Circadian Rhythm Disorder Treatment Breakdown Data by Type
4.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Historic Market Size by Type (2017-2022)
4.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Type (2023-2028)
5 Sleeplessness and Circadian Rhythm Disorder Treatment Breakdown Data by Application
5.1 Global Sleeplessness and Circadian Rhythm Disorder Treatment Historic Market Size by Application (2017-2022)
5.2 Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (2017-2028)
6.2 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2017-2022)
6.3 North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (2017-2028)
7.2 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2017-2022)
7.3 Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (2017-2028)
8.2 Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2017-2022)
8.3 Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (2017-2028)
9.2 Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2017-2022)
9.3 Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (2017-2028)
10.2 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2017-2022)
10.3 Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Lanaform
11.1.1 Lanaform Company Detail
11.1.2 Lanaform Business Overview
11.1.3 Lanaform Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.1.4 Lanaform Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
11.1.5 Lanaform Recent Development
11.2 Compass Health Brands (Carex Health)
11.2.1 Compass Health Brands (Carex Health) Company Detail
11.2.2 Compass Health Brands (Carex Health) Business Overview
11.2.3 Compass Health Brands (Carex Health) Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.2.4 Compass Health Brands (Carex Health) Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
11.2.5 Compass Health Brands (Carex Health) Recent Development
11.3 Compumedics
11.3.1 Compumedics Company Detail
11.3.2 Compumedics Business Overview
11.3.3 Compumedics Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.3.4 Compumedics Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
11.3.5 Compumedics Recent Development
11.4 Natus Medical
11.4.1 Natus Medical Company Detail
11.4.2 Natus Medical Business Overview
11.4.3 Natus Medical Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.4.4 Natus Medical Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
11.4.5 Natus Medical Recent Development
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Detail
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.5.4 Teva Pharmaceuticals Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
11.5.5 Teva Pharmaceuticals Recent Development
11.6 Lucimed (Luminette)
11.6.1 Lucimed (Luminette) Company Detail
11.6.2 Lucimed (Luminette) Business Overview
11.6.3 Lucimed (Luminette) Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.6.4 Lucimed (Luminette) Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
11.6.5 Lucimed (Luminette) Recent Development
11.7 Garmin
11.7.1 Garmin Company Detail
11.7.2 Garmin Business Overview
11.7.3 Garmin Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.7.4 Garmin Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
11.7.5 Garmin Recent Development
11.8 Koninklijke Philips
11.8.1 Koninklijke Philips Company Detail
11.8.2 Koninklijke Philips Business Overview
11.8.3 Koninklijke Philips Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.8.4 Koninklijke Philips Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
11.8.5 Koninklijke Philips Recent Development
11.9 Mylan
11.9.1 Mylan Company Detail
11.9.2 Mylan Business Overview
11.9.3 Mylan Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.9.4 Mylan Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
11.9.5 Mylan Recent Development
11.10 Fitbit
11.10.1 Fitbit Company Detail
11.10.2 Fitbit Business Overview
11.10.3 Fitbit Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.10.4 Fitbit Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
11.10.5 Fitbit Recent Development
11.11 Takeda Pharmaceutical
11.11.1 Takeda Pharmaceutical Company Detail
11.11.2 Takeda Pharmaceutical Business Overview
11.11.3 Takeda Pharmaceutical Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.11.4 Takeda Pharmaceutical Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
11.11.5 Takeda Pharmaceutical Recent Development
11.12 F.Hoffman La-Roche AG
11.12.1 F.Hoffman La-Roche AG Company Detail
11.12.2 F.Hoffman La-Roche AG Business Overview
11.12.3 F.Hoffman La-Roche AG Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.12.4 F.Hoffman La-Roche AG Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
11.12.5 F.Hoffman La-Roche AG Recent Development
11.13 Merck & Co. Inc.
11.13.1 Merck & Co. Inc. Company Detail
11.13.2 Merck & Co. Inc. Business Overview
11.13.3 Merck & Co. Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.13.4 Merck & Co. Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
11.13.5 Merck & Co. Inc. Recent Development
11.14 Pfizer, Inc.
11.14.1 Pfizer, Inc. Company Detail
11.14.2 Pfizer, Inc. Business Overview
11.14.3 Pfizer, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.14.4 Pfizer, Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
11.14.5 Pfizer, Inc. Recent Development
11.15 Pernix Therapeutics
11.15.1 Pernix Therapeutics Company Detail
11.15.2 Pernix Therapeutics Business Overview
11.15.3 Pernix Therapeutics Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.15.4 Pernix Therapeutics Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
11.15.5 Pernix Therapeutics Recent Development
11.16 Sanofi S.A.
11.16.1 Sanofi S.A. Company Detail
11.16.2 Sanofi S.A. Business Overview
11.16.3 Sanofi S.A. Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.16.4 Sanofi S.A. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
11.16.5 Sanofi S.A. Recent Development
11.17 Sumitomo Dainippon Pharma Co., Ltd
11.17.1 Sumitomo Dainippon Pharma Co., Ltd Company Detail
11.17.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
11.17.3 Sumitomo Dainippon Pharma Co., Ltd Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.17.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
11.17.5 Sumitomo Dainippon Pharma Co., Ltd Recent Development
11.18 Vanda Pharmaceuticals, Inc.
11.18.1 Vanda Pharmaceuticals, Inc. Company Detail
11.18.2 Vanda Pharmaceuticals, Inc. Business Overview
11.18.3 Vanda Pharmaceuticals, Inc. Sleeplessness and Circadian Rhythm Disorder Treatment Introduction
11.18.4 Vanda Pharmaceuticals, Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
11.18.5 Vanda Pharmaceuticals, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Drug Therapy
Table 3. Key Players of Light Therapy
Table 4. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Region (2017-2022)
Table 8. Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Region (2023-2028)
Table 10. Sleeplessness and Circadian Rhythm Disorder Treatment Market Trends
Table 11. Sleeplessness and Circadian Rhythm Disorder Treatment Market Drivers
Table 12. Sleeplessness and Circadian Rhythm Disorder Treatment Market Challenges
Table 13. Sleeplessness and Circadian Rhythm Disorder Treatment Market Restraints
Table 14. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Players (2017-2022)
Table 16. Global Top Sleeplessness and Circadian Rhythm Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment as of 2021)
Table 17. Ranking of Global Top Sleeplessness and Circadian Rhythm Disorder Treatment Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Sleeplessness and Circadian Rhythm Disorder Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Sleeplessness and Circadian Rhythm Disorder Treatment Product Solution and Service
Table 21. Date of Enter into Sleeplessness and Circadian Rhythm Disorder Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Type (2017-2022)
Table 25. Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Type (2023-2028)
Table 27. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Application (2017-2022)
Table 29. Global Sleeplessness and Circadian Rhythm Disorder Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Sleeplessness and Circadian Rhythm Disorder Treatment Revenue Market Share by Application (2023-2028)
Table 31. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 41. Lanaform Company Detail
Table 42. Lanaform Business Overview
Table 43. Lanaform Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 44. Lanaform Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022) & (US$ Million)
Table 45. Lanaform Recent Development
Table 46. Compass Health Brands (Carex Health) Company Detail
Table 47. Compass Health Brands (Carex Health) Business Overview
Table 48. Compass Health Brands (Carex Health) Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 49. Compass Health Brands (Carex Health) Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022) & (US$ Million)
Table 50. Compass Health Brands (Carex Health) Recent Development
Table 51. Compumedics Company Detail
Table 52. Compumedics Business Overview
Table 53. Compumedics Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 54. Compumedics Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022) & (US$ Million)
Table 55. Compumedics Recent Development
Table 56. Natus Medical Company Detail
Table 57. Natus Medical Business Overview
Table 58. Natus Medical Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 59. Natus Medical Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022) & (US$ Million)
Table 60. Natus Medical Recent Development
Table 61. Teva Pharmaceuticals Company Detail
Table 62. Teva Pharmaceuticals Business Overview
Table 63. Teva Pharmaceuticals Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 64. Teva Pharmaceuticals Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022) & (US$ Million)
Table 65. Teva Pharmaceuticals Recent Development
Table 66. Lucimed (Luminette) Company Detail
Table 67. Lucimed (Luminette) Business Overview
Table 68. Lucimed (Luminette) Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 69. Lucimed (Luminette) Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022) & (US$ Million)
Table 70. Lucimed (Luminette) Recent Development
Table 71. Garmin Company Detail
Table 72. Garmin Business Overview
Table 73. Garmin Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 74. Garmin Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022) & (US$ Million)
Table 75. Garmin Recent Development
Table 76. Koninklijke Philips Company Detail
Table 77. Koninklijke Philips Business Overview
Table 78. Koninklijke Philips Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 79. Koninklijke Philips Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022) & (US$ Million)
Table 80. Koninklijke Philips Recent Development
Table 81. Mylan Company Detail
Table 82. Mylan Business Overview
Table 83. Mylan Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 84. Mylan Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022) & (US$ Million)
Table 85. Mylan Recent Development
Table 86. Fitbit Company Detail
Table 87. Fitbit Business Overview
Table 88. Fitbit Sleeplessness and Circadian Rhythm Disorder Treatment Product
Table 89. Fitbit Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022) & (US$ Million)
Table 90. Fitbit Recent Development
Table 91. Takeda Pharmaceutical Company Detail
Table 92. Takeda Pharmaceutical Business Overview
Table 93. Takeda Pharmaceutical Sleeplessness and Circadian Rhythm Disorder TreatmentProduct
Table 94. Takeda Pharmaceutical Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022) & (US$ Million)
Table 95. Takeda Pharmaceutical Recent Development
Table 96. F.Hoffman La-Roche AG Company Detail
Table 97. F.Hoffman La-Roche AG Business Overview
Table 98. F.Hoffman La-Roche AG Sleeplessness and Circadian Rhythm Disorder TreatmentProduct
Table 99. F.Hoffman La-Roche AG Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022) & (US$ Million)
Table 100. F.Hoffman La-Roche AG Recent Development
Table 101. Merck & Co. Inc. Company Detail
Table 102. Merck & Co. Inc. Business Overview
Table 103. Merck & Co. Inc. Sleeplessness and Circadian Rhythm Disorder TreatmentProduct
Table 104. Merck & Co. Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022) & (US$ Million)
Table 105. Merck & Co. Inc. Recent Development
Table 106. Pfizer, Inc. Company Detail
Table 107. Pfizer, Inc. Business Overview
Table 108. Pfizer, Inc. Sleeplessness and Circadian Rhythm Disorder TreatmentProduct
Table 109. Pfizer, Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022) & (US$ Million)
Table 110. Pfizer, Inc. Recent Development
Table 111. Pernix Therapeutics Company Detail
Table 112. Pernix Therapeutics Business Overview
Table 113. Pernix Therapeutics Sleeplessness and Circadian Rhythm Disorder TreatmentProduct
Table 114. Pernix Therapeutics Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022) & (US$ Million)
Table 115. Pernix Therapeutics Recent Development
Table 116. Sanofi S.A. Company Detail
Table 117. Sanofi S.A. Business Overview
Table 118. Sanofi S.A. Sleeplessness and Circadian Rhythm Disorder TreatmentProduct
Table 119. Sanofi S.A. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022) & (US$ Million)
Table 120. Sanofi S.A. Recent Development
Table 121. Sumitomo Dainippon Pharma Co., Ltd Company Detail
Table 122. Sumitomo Dainippon Pharma Co., Ltd Business Overview
Table 123. Sumitomo Dainippon Pharma Co., Ltd Sleeplessness and Circadian Rhythm Disorder TreatmentProduct
Table 124. Sumitomo Dainippon Pharma Co., Ltd Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022) & (US$ Million)
Table 125. Sumitomo Dainippon Pharma Co., Ltd Recent Development
Table 126. Vanda Pharmaceuticals, Inc. Company Detail
Table 127. Vanda Pharmaceuticals, Inc. Business Overview
Table 128. Vanda Pharmaceuticals, Inc. Sleeplessness and Circadian Rhythm Disorder TreatmentProduct
Table 129. Vanda Pharmaceuticals, Inc. Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022) & (US$ Million)
Table 130. Vanda Pharmaceuticals, Inc. Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Type: 2021 VS 2028
Figure 2. Drug Therapy Features
Figure 3. Light Therapy Features
Figure 4. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Application in 2021 & 2028
Figure 5. Hospital Case Studies
Figure 6. Specialist Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Sleeplessness and Circadian Rhythm Disorder Treatment Report Years Considered
Figure 9. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Region: 2021 VS 2028
Figure 12. Global Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Players in 2021
Figure 13. Global Top Sleeplessness and Circadian Rhythm Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleeplessness and Circadian Rhythm Disorder Treatment as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Sleeplessness and Circadian Rhythm Disorder Treatment Revenue in 2021
Figure 15. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Country (2017-2028)
Figure 17. United States Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Country (2017-2028)
Figure 21. Germany Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Region (2017-2028)
Figure 29. China Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Country (2017-2028)
Figure 37. Mexico Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Sleeplessness and Circadian Rhythm Disorder Treatment Market Share by Country (2017-2028)
Figure 41. Turkey Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Sleeplessness and Circadian Rhythm Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Lanaform Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
Figure 44. Compass Health Brands (Carex Health) Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
Figure 45. Compumedics Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
Figure 46. Natus Medical Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
Figure 47. Teva Pharmaceuticals Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
Figure 48. Lucimed (Luminette) Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
Figure 49. Garmin Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
Figure 50. Koninklijke Philips Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
Figure 51. Mylan Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
Figure 52. Fitbit Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
Figure 53. Takeda Pharmaceutical Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
Figure 54. F.Hoffman La-Roche AG Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
Figure 55. Merck & Co. Inc. Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
Figure 56. Pfizer, Inc. Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
Figure 57. Pernix Therapeutics Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
Figure 58. Sanofi S.A. Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
Figure 59. Sumitomo Dainippon Pharma Co., Ltd Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
Figure 60. Vanda Pharmaceuticals, Inc. Revenue Growth Rate in Sleeplessness and Circadian Rhythm Disorder Treatment Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
